Amicus Therapeutics, Inc. (FOLD) — POSASR Filings
All POSASR filings from Amicus Therapeutics, Inc.. Browse 7 POSASR reports with AI-powered summaries and risk analysis.
POSASR Filings (7)
-
Amicus Therapeutics Files POSASR Amendment
— Apr 27, 2026 Risk: low
Amicus Therapeutics, Inc. filed a Post-effective Amendment to an automatic shelf registration statement (POSASR) on April 27, 2026. This filing, with SEC Access -
Amicus Therapeutics Files POSASR Amendment
— Apr 27, 2026 Risk: low
Amicus Therapeutics, Inc. filed a Post-effective Amendment to an automatic shelf registration statement (POSASR) on April 27, 2026. This filing relates to the c -
Amicus Therapeutics Files Post-Effective Amendment
— Apr 27, 2026 Risk: low
Amicus Therapeutics, Inc. filed a Post-effective Amendment to an automatic shelf registration statement (POSASR) on April 27, 2026. This filing relates to the e - POSASR Filing — Apr 27, 2026
- POSASR Filing — Apr 27, 2026
-
Amicus Therapeutics Files POSASR Amendment
— Apr 27, 2026 Risk: low
Amicus Therapeutics, Inc. filed a Post-effective Amendment to an automatic shelf registration statement (POSASR) on April 27, 2026. This filing, with SEC Access - POSASR Filing — Apr 27, 2026
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX